China NMPA Product Recall - Spinal surgical tools

The National Medical Products Administration (NMPA) issued a notice on November 7, 2013, concerning a voluntary recall initiated by Synthes GmbH for specific spinal surgical instruments. The recall stemmed from a critical manufacturing issue: the use of incorrect raw materials. It was discovered that a batch of materials, intended to be 420A, was inadvertently contaminated with X20CrMnNi 12 8 6, a non-magnetic austenitic steel. This material deviation would result in the affected instruments having compromised hardness and reduced corrosion resistance, potentially impacting their performance and safety. The recall primarily affects overseas markets, including Spain, Switzerland, the Netherlands, the USA, and Canada. Johnson & Johnson (Shanghai) Medical Devices Co., Ltd., representing Synthes in China, formally reported to the State Food and Drug Administration that this recall does not involve the Chinese market. No affected products were imported or sold in China. Consequently, no specific recall actions are required domestically. However, the NMPA mandated that regional food and drug administration departments reinforce their oversight and management of such medical devices to uphold product quality and regulatory compliance.